Excellent outcomes and lack of prognostic impact of cell of origin for localized diffuse large B‐cell lymphoma in the rituximab era

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|171|5|776-783

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.171, Iss.5, 2015-12, pp. : 776-783

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Prognostic Impact of Absolute Lymphocyte and Monocyte Counts at Diagnosis of Diffuse Large B-Cell Lymphoma in the Rituximab Era

By  

Acta Haematologica, Vol. 130, Iss. 4, 2013-07 ,pp. : 242-246

Karger

Access to resources Recommend Favorite

Radiation for diffuse large B‐cell lymphoma in the rituximab era: Analysis of the National Comprehensive Cancer Network lymphoma outcomes project

By  

CANCER, Vol. 121, Iss. 7, 2015-04 ,pp. : 1032-1039

John Wiley & Sons Inc

Access to resources Recommend Favorite

Differential Therapy for Diffuse Large B-Cell Lymphoma with Different Cells of Origin

By  

Oncology Research and Treatment, Vol. 32, Iss. 12, 2009-11 ,pp. : 711-712

Karger

Access to resources Recommend Favorite

Risk‐tailored CNS prophylaxis in a mono‐institutional series of 200 patients with diffuse large B‐cell lymphoma treated in the rituximab era

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 5, 2015-03 ,pp. : 654-662

John Wiley & Sons Inc

Access to resources Recommend Favorite

Additional Support for Consolidative Radiotherapy for Diffuse Large B Cell Lymphoma in the Modern Rituximab Era

By  

Acta Haematologica, Vol. 134, Iss. 2, 2015-04 ,pp. : 109-110

Karger

Access to resources Recommend Favorite